Junion
Latest round
- Series A
Last raised
- Apr 2025
Total raised
- $14M
Investors
- 6
About Junion
Established in 2021 and based in Xiamen, China, Junion operates as an innovative therapies developer that mainly provides innovative treatments for chronic diseases throughout their entire life cycle. It has R&D centers and production bases in Singapore and Xiamen. The company has obtained more than 20 patents. The company focuses on the development of innovative treatments for chronic diseases throughout the entire cycle, and uses materials science, pharmacy, biology, machine learning, and other disciplines and technologies to develop drug-device combination products. Products include gastric volume weight loss capsules (JTX-102) and risperidone oral delivery systems. JTX-102 is an oral device used to help overweight or obese adults treat obesity symptoms or manage their weight. Products focus on chronic diseases such as mental illness, obesity, diabetes, and metabolic-related fatty liver. The company generates revenue by providing drug-device combination products and innovative treatments for chronic diseases.
Who invested in Junion
6 investors across 1 round
See all investors in Junion
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Apr 18, 2025
Amount
$14M
Investors
Questions about Junion
Who invested in Junion?
Junion has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Junion raised?
Junion has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Junion last raise money?
Junion's most recent round on record is a Series A, in Apr 2025.
What does Junion do?
Established in 2021 and based in Xiamen, China, Junion operates as an innovative therapies developer that mainly provides innovative treatments for chronic diseases throughout their entire life cycle.
Where is Junion headquartered?
Junion is headquartered in Xiamen, China.
Which VCs invest in companies like Junion?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Junion's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Junion? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.